Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8308 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.8162 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.8032 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.8032 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.7979 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.7979 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.7979 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.7959 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.7946 |
Intermediate Similarity |
NPD482 |
Approved |
0.794 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7923 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.79 |
Intermediate Similarity |
NPD7001 |
Phase 3 |
0.79 |
Intermediate Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7876 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7822 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7822 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7789 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7723 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.7685 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7672 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7668 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7659 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD7666 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD7665 |
Phase 2 |
0.7629 |
Intermediate Similarity |
NPD8431 |
Approved |
0.7585 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7549 |
Intermediate Similarity |
NPD2008 |
Discontinued |
0.7549 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.7549 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.7537 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7524 |
Intermediate Similarity |
NPD5818 |
Discontinued |
0.7512 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7512 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3947 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2411 |
Approved |
0.75 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD4852 |
Phase 2 |
0.7488 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7488 |
Intermediate Similarity |
NPD8073 |
Approved |
0.7488 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7476 |
Intermediate Similarity |
NPD3389 |
Approved |
0.7476 |
Intermediate Similarity |
NPD3394 |
Approved |
0.7476 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7476 |
Intermediate Similarity |
NPD3393 |
Approved |
0.7475 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7454 |
Intermediate Similarity |
NPD6165 |
Phase 2 |
0.7454 |
Intermediate Similarity |
NPD6164 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD8072 |
Approved |
0.745 |
Intermediate Similarity |
NPD4848 |
Phase 1 |
0.7411 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD2144 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4501 |
Approved |
0.7389 |
Intermediate Similarity |
NPD484 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4500 |
Approved |
0.7378 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.7364 |
Intermediate Similarity |
NPD7791 |
Approved |
0.7364 |
Intermediate Similarity |
NPD7952 |
Approved |
0.7364 |
Intermediate Similarity |
NPD7953 |
Approved |
0.7364 |
Intermediate Similarity |
NPD7950 |
Approved |
0.7364 |
Intermediate Similarity |
NPD7951 |
Approved |
0.7364 |
Intermediate Similarity |
NPD7790 |
Approved |
0.7364 |
Intermediate Similarity |
NPD7789 |
Approved |
0.7363 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.735 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.735 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.735 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7345 |
Intermediate Similarity |
NPD786 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7339 |
Intermediate Similarity |
NPD7780 |
Approved |
0.7339 |
Intermediate Similarity |
NPD7781 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3320 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3319 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD3318 |
Approved |
0.7331 |
Intermediate Similarity |
NPD7393 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD5473 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7313 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7304 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7304 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7289 |
Intermediate Similarity |
NPD3914 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD5088 |
Discontinued |
0.7282 |
Intermediate Similarity |
NPD6176 |
Phase 1 |
0.7282 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.7281 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7277 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6454 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7269 |
Intermediate Similarity |
NPD6995 |
Phase 1 |
0.7268 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7268 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7263 |
Intermediate Similarity |
NPD1722 |
Approved |
0.7263 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7263 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD5482 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7233 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7227 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7227 |
Intermediate Similarity |
NPD5801 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6531 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6530 |
Approved |
0.722 |
Intermediate Similarity |
NPD6479 |
Discontinued |
0.7217 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD3506 |
Approved |
0.7216 |
Intermediate Similarity |
NPD3505 |
Approved |
0.7213 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.7204 |
Intermediate Similarity |
NPD276 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD6160 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD4429 |
Discontinued |
0.7157 |
Intermediate Similarity |
NPD2880 |
Discontinued |
0.7157 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD2881 |
Approved |
0.715 |
Intermediate Similarity |
NPD2879 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2479 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD2481 |
Approved |
0.7136 |
Intermediate Similarity |
NPD4845 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD4987 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.712 |
Intermediate Similarity |
NPD2642 |
Approved |
0.712 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7688 |
Phase 1 |
0.7116 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD4736 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.71 |
Intermediate Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD3905 |
Phase 3 |
0.7094 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7087 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD8282 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3835 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8283 |
Approved |
0.7081 |
Intermediate Similarity |
NPD56 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD3833 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD4051 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD2443 |
Approved |
0.7062 |
Intermediate Similarity |
NPD2442 |
Approved |
0.7056 |
Intermediate Similarity |
NPD1291 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.7054 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4922 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD4614 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD5475 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD7865 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5559 |
Phase 2 |
0.7023 |
Intermediate Similarity |
NPD7970 |
Approved |
0.7023 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD5017 |
Discontinued |
0.7015 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD8322 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD6137 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7424 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6288 |
Clinical (unspecified phase) |
0.6996 |
Remote Similarity |
NPD4952 |
Phase 3 |
0.6995 |
Remote Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD2336 |
Approved |
0.6991 |
Remote Similarity |
NPD3006 |
Discontinued |
0.6991 |
Remote Similarity |
NPD5612 |
Discontinued |
0.6985 |
Remote Similarity |
NPD5106 |
Approved |
0.6985 |
Remote Similarity |
NPD5105 |
Approved |
0.6983 |
Remote Similarity |
NPD4558 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD6459 |
Phase 2 |
0.698 |
Remote Similarity |
NPD1534 |
Approved |
0.698 |
Remote Similarity |
NPD7234 |
Approved |
0.698
|
Remote Similarity |
NPD7233 |
Approved |